Anteris Technologies Global (AVR) and Its Competitors Financial Survey

Anteris Technologies Global (NASDAQ:AVR) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its peers? We will compare Anteris Technologies Global to similar companies based on the strength of its institutional ownership, risk, valuation, earnings, dividends, analyst recommendations and profitability.

Risk and Volatility

Anteris Technologies Global has a beta of 2.02, indicating that its share price is 102% more volatile than the S&P 500. Comparatively, Anteris Technologies Global’s peers have a beta of 2.57, indicating that their average share price is 157% more volatile than the S&P 500.

Earnings & Valuation

This table compares Anteris Technologies Global and its peers revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Anteris Technologies Global	$1.91 million	-$94.14 million	-3.24
Anteris Technologies Global Competitors	$1.89 billion	$138.79 million	10.75

Anteris Technologies Global’s peers have higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Institutional and Insider Ownership

40.6% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 4.5% of Anteris Technologies Global shares are owned by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Anteris Technologies Global and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-4,619.27%	-77.69%	-67.99%
Anteris Technologies Global Competitors	-278.23%	-150.06%	-21.87%

Analyst Ratings

This is a breakdown of recent ratings for Anteris Technologies Global and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1	1	3	0	2.40
Anteris Technologies Global Competitors	4257	10483	18210	824	2.46

Anteris Technologies Global presently has a consensus price target of $14.00, indicating a potential upside of 121.87%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 25.74%. Given Anteris Technologies Global’s higher possible upside, equities research analysts plainly believe Anteris Technologies Global is more favorable than its peers.

Summary

Anteris Technologies Global peers beat Anteris Technologies Global on 10 of the 13 factors compared.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.